Technical Analysis for CRY - CryoLife, Inc.

Grade Last Price % Change Price Change
grade B 30.16 -0.26% -0.08
CRY closed down 0.26 percent on Thursday, January 23, 2020, on 1.23 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Feb 12
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CRY trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Walk Strength -0.26%
Multiple of Ten Bullish Other -0.26%
Inside Day Range Contraction -0.26%
Overbought Stochastic Strength -0.26%
Up 3 Days in a Row Strength -0.26%
Up 4 Days in a Row Strength -0.26%
Up 5 Days in a Row Strength -0.26%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications. It distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using CryoLife's proprietary SynerGraft technology; and vascular tissues comprising CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company also distributes surgical sealants and hemostats, including BioGlue Surgical Adhesive, an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels, as well as in repair of cardiac, vascular, pulmonary, and additional soft tissues. In addition, its surgical sealants and hemostats comprise BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; PerClot, an absorbable powdered hemostat agent used in surgery; and revascularization technologies, which include transmyocardial revascularization system for treating patients with stable angina that is not responsive to conventional therapy. CryoLife, through its subsidiary Cardiogenesis Corporation, specializes in the treatment of coronary artery disease for severe angina using a laser console system and single use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization. The company, through its subsidiary, Hemosphere, Inc., markets HeRO Graft, a solution for end-stage renal disease in certain hemodialysis patients. CryoLife distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Medicine Laser Surgery Hemodialysis Circulatory System End Stage Renal Disease Transplantation Vascular Surgery Bypass Cardiovascular System Coronary Artery Disease Treatment Of Coronary Artery Disease

Is CRY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 33.0
52 Week Low 20.76
Average Volume 172,322
200-Day Moving Average 27.54
50-Day Moving Average 26.30
20-Day Moving Average 28.29
10-Day Moving Average 29.37
Average True Range 0.62
ADX 43.21
+DI 31.56
-DI 6.16
Chandelier Exit (Long, 3 ATRs ) 28.65
Chandelier Exit (Short, 3 ATRs ) 27.27
Upper Bollinger Band 30.76
Lower Bollinger Band 25.81
Percent B (%b) 0.88
BandWidth 17.50
MACD Line 1.14
MACD Signal Line 0.99
MACD Histogram 0.143
Fundamentals Value
Market Cap 1.01 Billion
Num Shares 33.4 Million
EPS 0.33
Price-to-Earnings (P/E) Ratio 91.39
Price-to-Sales 3.65
Price-to-Book 3.05
PEG Ratio 1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.75
Resistance 3 (R3) 30.74 30.52 30.65
Resistance 2 (R2) 30.52 30.37 30.53 30.62
Resistance 1 (R1) 30.34 30.28 30.24 30.36 30.59
Pivot Point 30.13 30.13 30.08 30.14 30.13
Support 1 (S1) 29.95 29.98 29.84 29.96 29.73
Support 2 (S2) 29.73 29.88 29.74 29.70
Support 3 (S3) 29.55 29.73 29.67
Support 4 (S4) 29.57